US Patent Issued to GlaxoSmithKline Intellectual Property Development on July 7 for "CR2 binding proteins and their use in medical therapy" (British Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,990, issued on July 7, was assigned to GlaxoSmithKline Intellectual Property Development Ltd. (Great Britain).

"CR2 binding proteins and their use in medical therapy" was invented by James Matthew Bailey (Stevenage, Great Britain), Gerben Bouma (Stevenage, Great Britain), Michael Neil Burden (Stevenage, Great Britain), Caroline J. Dimech (Stevenage, Great Britain), David Dixon (Stevenage, Great Britain), Gabriela Dos Santos Cruz De Mantos (Stevenage, Great Britain), Christian Ellson (Stevenage, Great Britain), Laura J. Hook (Stevenage, Great Britain), Semra Kitchen (Stevenage, Great Britain), Eleonora Lekova (Stevenage, Great Britain), Emilie Madura (Stevenage, Great Britain), Kira...